KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Cash (2016 - 2025)

Fulgent Genetics' Change in Cash history spans 10 years, with the latest figure at -$67.4 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 2227.4% year-over-year to -$67.4 million; the TTM value through Dec 2025 reached -$5.0 million, up 88.27%, while the annual FY2025 figure was -$5.0 million, 88.27% up from the prior year.
  • Change in Cash for Q4 2025 was -$67.4 million at Fulgent Genetics, down from $29.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $188.2 million in Q1 2022 and bottomed at -$214.3 million in Q2 2022.
  • The 5-year median for Change in Cash is $3.8 million (2024), against an average of -$1.9 million.
  • The largest annual shift saw Change in Cash skyrocketed 2504.62% in 2021 before it crashed 2227.4% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$50.0 million in 2021, then tumbled by 78.59% to -$89.3 million in 2022, then skyrocketed by 115.01% to $13.4 million in 2023, then tumbled by 121.63% to -$2.9 million in 2024, then plummeted by 2227.4% to -$67.4 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Change in Cash are -$67.4 million (Q4 2025), $29.8 million (Q3 2025), and $20.6 million (Q2 2025).